NUCALA: payments to doctors
Payments that named NUCALA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $31.3M
- Providers
- 32,938
- Transactions
- 380,705
- Average per transaction
- $82
The per-transaction average — $82 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 32,938 providers the average total is $951, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| GSK | $31,308,382 | 100.0% |